Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision number was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s version. This update appears to be a non-substantive administrative change rather than a modification to study details or eligibility criteria.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend update to the site’s template or CMS without altering study content or visible functions.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a system update rather than changes to the study content. No study data or user-facing content appears to be altered.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3. This indicates a small update to the record, typically reflecting editorial or formatting adjustments rather than changes to the study details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update to the page metadata rather than a substantive change to content.SummaryDifference0.1%

- Check90 days agoChange DetectedNew guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and a recruitment status note states that the study is no longer looking for participants. The Interventions header has been reformatted to Intervention/Treatment and the page revision footer updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.